MedTrace Logo

National Education Programme for Patients With Chronic Adrenal Insufficiency

NCT02694926 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 528

Last updated 2018-01-23

No results posted yet for this study

Summary

Even under established replacement therapy, patients with adrenal insufficiency still suffer from impaired quality of life and experience adrenal crises. Patient education is regarded as important preventive measure. In this study a german-wide standardized education Programme will be evaluated.

Conditions

Interventions

OTHER

Education

During a session of 90 minutes duration, patients are educated in basic knowledge on adrenal insufficiency including the correct behaviour in emergency settings.

Sponsors & Collaborators

  • Dr. Michael Droste, Elisenstraße 12, 26122 Oldenburg

    collaborator UNKNOWN

  • Prof. Dr. Marcus Quinkler, Praxis für Endokrinologie,10627 Berlin

    collaborator UNKNOWN

  • Dr. Gesine Meyer, Universitätsklinikum Frankfurt, 60590 Frankfurt am Main

    collaborator UNKNOWN

  • PD Dr. Nicole Reisch, LMU München, D-80336 München

    collaborator UNKNOWN

  • Prof. Dr. Holger Willenberg, Zentrum für Innere Medizin, D-18057 Rostock

    collaborator UNKNOWN

  • Prof. Johannes Klein, Zentrum Endokrine Medizin, 23564 Lübeck

    collaborator UNKNOWN

  • Charite University, Berlin, Germany

    collaborator OTHER

  • MVZ Endokrinologikum Saarbrücken, Europaallee 15, 66113 Saarbrücken

    collaborator UNKNOWN

  • Wuerzburg University Hospital

    lead OTHER

Principal Investigators

  • Stefanie Hahner, MD, Prof. · University Hospital Wuerzburg

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2017-11-30
Completion
2017-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02694926 on ClinicalTrials.gov